Progress in allergy management: Allergen-specific immunotherapy

Harold S. Nelson, Philip S. Norman

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Specific immunotherapy was introduced for the treatment of grass pollen-induced hay fever in 1911. The treatment was soon extended to other pollens as well as perennial allergens, and to the treatment of bronchial asthma. Definitive studies of its efficacy for both rhinitis and asthma came only many decades later. Understanding gradually emerged of the underlying immunologic mechanisms that include the generation of regulatory T lymphocytes, immune deviation from allergen-specific Th2 to Th1 responses, and a shift in allergen- specific antibody production from immunoglobulin (Ig) E to IgG4. Along with understanding of the immune basis came an appreciation that immunotherapy modifies allergic disease expression, producing protection against disease progression and symptomatic improvement that persists for years after the treatment is discontinued. Recent new directions for immunotherapy include sublingual administration of inhalant allergens and use of the oral route to treat food allergy.

Original languageEnglish (US)
Title of host publicationHistory of Allergy
PublisherS. Karger AG
Pages333-338
Number of pages6
Volume100
ISBN (Print)9783318021950, 9783318021943
DOIs
StatePublished - May 27 2014

Fingerprint

Immunologic Desensitization
Allergens
Hypersensitivity
Immunotherapy
Pollen
Asthma
Sublingual Administration
Seasonal Allergic Rhinitis
Food Hypersensitivity
Regulatory T-Lymphocytes
Therapeutics
Rhinitis
Poaceae
Immunoglobulin E
Antibody Formation
Disease Progression
Immunoglobulin G

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)

Cite this

Nelson, H. S., & Norman, P. S. (2014). Progress in allergy management: Allergen-specific immunotherapy. In History of Allergy (Vol. 100, pp. 333-338). S. Karger AG. https://doi.org/10.1159/000360047

Progress in allergy management : Allergen-specific immunotherapy. / Nelson, Harold S.; Norman, Philip S.

History of Allergy. Vol. 100 S. Karger AG, 2014. p. 333-338.

Research output: Chapter in Book/Report/Conference proceedingChapter

Nelson, HS & Norman, PS 2014, Progress in allergy management: Allergen-specific immunotherapy. in History of Allergy. vol. 100, S. Karger AG, pp. 333-338. https://doi.org/10.1159/000360047
Nelson HS, Norman PS. Progress in allergy management: Allergen-specific immunotherapy. In History of Allergy. Vol. 100. S. Karger AG. 2014. p. 333-338 https://doi.org/10.1159/000360047
Nelson, Harold S. ; Norman, Philip S. / Progress in allergy management : Allergen-specific immunotherapy. History of Allergy. Vol. 100 S. Karger AG, 2014. pp. 333-338
@inbook{8a944ce6e09147ddace5532c3b0bdf93,
title = "Progress in allergy management: Allergen-specific immunotherapy",
abstract = "Specific immunotherapy was introduced for the treatment of grass pollen-induced hay fever in 1911. The treatment was soon extended to other pollens as well as perennial allergens, and to the treatment of bronchial asthma. Definitive studies of its efficacy for both rhinitis and asthma came only many decades later. Understanding gradually emerged of the underlying immunologic mechanisms that include the generation of regulatory T lymphocytes, immune deviation from allergen-specific Th2 to Th1 responses, and a shift in allergen- specific antibody production from immunoglobulin (Ig) E to IgG4. Along with understanding of the immune basis came an appreciation that immunotherapy modifies allergic disease expression, producing protection against disease progression and symptomatic improvement that persists for years after the treatment is discontinued. Recent new directions for immunotherapy include sublingual administration of inhalant allergens and use of the oral route to treat food allergy.",
author = "Nelson, {Harold S.} and Norman, {Philip S.}",
year = "2014",
month = "5",
day = "27",
doi = "10.1159/000360047",
language = "English (US)",
isbn = "9783318021950",
volume = "100",
pages = "333--338",
booktitle = "History of Allergy",
publisher = "S. Karger AG",

}

TY - CHAP

T1 - Progress in allergy management

T2 - Allergen-specific immunotherapy

AU - Nelson, Harold S.

AU - Norman, Philip S.

PY - 2014/5/27

Y1 - 2014/5/27

N2 - Specific immunotherapy was introduced for the treatment of grass pollen-induced hay fever in 1911. The treatment was soon extended to other pollens as well as perennial allergens, and to the treatment of bronchial asthma. Definitive studies of its efficacy for both rhinitis and asthma came only many decades later. Understanding gradually emerged of the underlying immunologic mechanisms that include the generation of regulatory T lymphocytes, immune deviation from allergen-specific Th2 to Th1 responses, and a shift in allergen- specific antibody production from immunoglobulin (Ig) E to IgG4. Along with understanding of the immune basis came an appreciation that immunotherapy modifies allergic disease expression, producing protection against disease progression and symptomatic improvement that persists for years after the treatment is discontinued. Recent new directions for immunotherapy include sublingual administration of inhalant allergens and use of the oral route to treat food allergy.

AB - Specific immunotherapy was introduced for the treatment of grass pollen-induced hay fever in 1911. The treatment was soon extended to other pollens as well as perennial allergens, and to the treatment of bronchial asthma. Definitive studies of its efficacy for both rhinitis and asthma came only many decades later. Understanding gradually emerged of the underlying immunologic mechanisms that include the generation of regulatory T lymphocytes, immune deviation from allergen-specific Th2 to Th1 responses, and a shift in allergen- specific antibody production from immunoglobulin (Ig) E to IgG4. Along with understanding of the immune basis came an appreciation that immunotherapy modifies allergic disease expression, producing protection against disease progression and symptomatic improvement that persists for years after the treatment is discontinued. Recent new directions for immunotherapy include sublingual administration of inhalant allergens and use of the oral route to treat food allergy.

UR - http://www.scopus.com/inward/record.url?scp=84922389234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922389234&partnerID=8YFLogxK

U2 - 10.1159/000360047

DO - 10.1159/000360047

M3 - Chapter

C2 - 24925414

AN - SCOPUS:84922389234

SN - 9783318021950

SN - 9783318021943

VL - 100

SP - 333

EP - 338

BT - History of Allergy

PB - S. Karger AG

ER -